ICU Medical. has been granted a patent for a medication delivery system that utilizes a controller with a closed loop control algorithm. This system monitors patient conditions and adjusts drug delivery based on predetermined risk thresholds, ensuring clinician intervention when necessary. GlobalData’s report on ICU Medical gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on ICU Medical, Wearable infusion devices was a key innovation area identified from patents. ICU Medical's grant share as of June 2024 was 49%. Grant share is based on the ratio of number of grants to total number of patents.
Automated medication delivery and monitoring system
The granted patent US12042631B2 outlines a system and method for operating an infusion system designed to deliver drugs to patients. Central to this innovation is a configuration of one or more hardware processors that communicate with a pump controller to manage drug delivery at a specified infusion rate. The system is capable of detecting failures in the infusion process, such as air in the infusion line or occlusions, and assesses the risk of stopping drug delivery due to these failures. Based on this risk assessment, the system can decide whether to continue delivering the original drug or switch to administering a different drug at an alternative infusion rate through a separate channel.
The patent further specifies that the drugs involved may include glucose, dextrose, or insulin. It also details functionalities such as notifying a remote system or clinician about detected failures and the ability to deliver drugs at a predetermined rate following a failure. Additionally, the risk assessment can be conducted by a supervisory computing system that operates independently of the infusion system. The system is designed to enhance patient safety by allowing for the complete cessation of drug delivery if the risk of stopping is deemed lower than the risk associated with the detected failure. This multifaceted approach aims to improve the reliability and effectiveness of infusion therapies.
To know more about GlobalData’s detailed insights on ICU Medical, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
